Latest Systemic lupus erythematosus Stories
Lupus Science & Medicine is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus WASHINGTON, April 3, 2014
The code for every gene includes a message at the end of it that signals the translation machinery to stop.
- Agreement aims to identify biomarkers relevant to future therapies in the area of Systemic Lupus Erythematosus and Lupus Nephritis ROCKLAND, Mass., April 1, 2014 /PRNewswire/
New England Patriots defensive back Tavon Wilson serves as Walk Ambassador WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality
HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"),
LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America
Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com.
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, March 17, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of clinical studies with
HAYWARD, Calif., March 12, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.